ad

Amanta Healthcare IPO GMP & Review: Apply or Avoid?

Posted by : sachet | Sat Aug 30 2025

Amanta Healthcare IPO GMP & Review: Apply or Avoid?

Amanta Healthcare IPO is open for bidding from 1st September 2025 to 3rd September 2025. It is a bookbuilding IPO of  ₹126.00 crore, comprising a fresh issue of 1.00 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 9th September 2025. 

Amanta Healthcare IPO Details 

The Amanta Healthcare IPO date is fixed between 1st September 2025 to 3rd September 2025. The face value of Amanta Healthcare IPO shares stands at ₹10 per share, and the IPO price is set at ₹120.00 to 126.00 per share.

MUFG Intime India Private Limited is the registrar of the Amanta Healthcare IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

IPO Open Date1st September 2025
IPO Close Date3rd September 2025
IPO Allotment Date4th September 2025
Refund Initiation 8th September 2025
Issue Size1,00,00,000 shares(aggregating up to ₹126.00 Cr)
Face Value₹10 per share
Lot Size119 shares
Issue Price Band₹120.00 to ₹126.00 per share
Issue TypeBookbuilding IPO
Listing AtBSE & SME
Listing Date9th September 2025

Amanta Healthcare IPO Share Reservation

Amanta Healthcare IPO is a bookbuilding IPO of ₹126.00 crores, comprising a fresh issue of 1.00 crore shares of Amanta Healthcare shares will be listed on the BSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Investor CategoriesShares Offered
QIB Shares OfferedNot more than 50.00% of the Net Issue
Retail Shares OfferedNot less than 35.00% of the Net Issue
NII (HNI) Shares OfferedNot less than 15.00% of the Net Issue

Amanta Healthcare IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Amanta Healthcare IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

GMP DateIPO PriceGMPEstimated Listing Price Estimated Listing Gains
29-08-2025₹126.00₹25.00₹151.0019.84%
28-08-2025₹126.00₹22.00₹148.0017.46%
27-08-2025₹126.00₹22.00₹148.0017.46%
26-08-2025₹126.00₹22.00₹148.0017.46%
25-08-2025₹20.00₹146.0015.87%
24-08-2025₹0.00₹0.000.00%
23-08-2025

As of 29th August 2025, Amanta Healthcare IPO GMP stands at ₹25 per share, which means the share will likely show a listing at ₹151 on its tentative listing date, 9th September 2025.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Amanta Healthcare GMP. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends. 

Amanta Healthcare IPO GMP Review

Check out the detailed Amanta Healthcare GMP IPO review for a thorough understanding of its potential to report listing gains on 9th September 2025. The Amanta Healthcare IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the growth margins and declines of the business’s financials before applying for the Amanta Healthcare IPO.

Amanta Healthcare Limited’s revenue increased by 2% from ₹281.61 crores in March 2024 to ₹276.09 crores in March 2025. Moreover, the company’s PAT rose by 189% from ₹3.63 crores to ₹10.50 crores.

Amanta Healthcare Limited’s IPO has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for the Amanta Healthcare IPO for its tentative listing day, 9th September 2025.  

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Amanta Healthcare IPO.

Key IndicatorsValue
PE Ratio (Price-to-Earnings) 34.59
EPS (Earnings Per Share)3.64
RoNW10.89%
ROCE13.72%
ROE12.42%
EBITDA Margin22.11%
Price to Book Value3.77
Market Capitalisation₹489.25 Cr

The P/E ratio of Amanta Healthcare Limited’s share is 34.59, and its Earnings Per Share (EPS) stands at 3.64. Thus, the Amanta Healthcare Limited IPO can potentially deliver gains on its tentative listing date, 9th September 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Amanta Healthcare Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

IndicatorsPre-IPOPost-IPO
PE Ratio34.5946.59
EPS 3.642.70

Amanta Healthcare IPO Subscription Status

The Amanta Healthcare IPO is to be opened for bidding on 1st September 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Amanta Healthcare IPO subscription status. 

Investor CategoryShares OfferedShares SubscribedSubscription to the Times
QIB Shares OfferedNot more than 50.00% of the Net IssueYet to be announcedYet to be announced
Retail Shares OfferedNot less than 35.00% of the Net IssueYet to be announcedYet to be announced
NII (HNI) Shares OfferedNot less than 15.00% of the Net IssueYet to be announcedYet to be announced

About Amanta Healthcare Limited

Amanta Healthcare Limited was established in December 1994. Amanta Healthcare Limited is a pharmaceutical company that specialises in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilising Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.

The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.

Amanta Healthcare Limited Financials

The company’s financial analysis is essential before applying for the Amanta Healthcare  IPO. Look at the table to learn about Amanta Healthcare Limited’s financials. 

Year Ended31st March 2025 (in cr.)31st March 2024 (in cr.)31st March 2023 (in cr.)
Assets381.76352.12374.06
Revenue276.09281.61262.70
Profit After ax10.503.63-2.11
EBITDA61.0558.7656.31
Net Worth96.3966.2962.88
Reserve and surplus67.5639.4636.05
Total Borrowing195.00205.23215.66

Explanation

Amanta Healthcare Limited’s revenue increased by 2% from ₹281.61 crores in March 2024 to ₹276.09 crores in March 2025. Moreover, the company’s PAT rose by 189% from ₹3.63 crores to ₹10.50 crores.

Amanta Healthcare IPO Bidding Requirements

Investors can bid for a minimum of 119 shares and in multiples of 119 shares thereof. The following table represents the minimum and maximum investments by individual investors (retail) and HNI in terms of shares and amount.

Application Lots Shares Amount
Individual Investors (Retail) (Min)1119₹14,994
Individual Investors (Retail) (Max131,547₹1,94,922
S-HNI (Min)141,666₹2,09,916
S-HNI (Max)667,854₹9,89,604
B-HNI (Min)677,973₹10,04,598

Amanta Healthcare IPO has reserved lot sizes for different investor categories. Look at the table below to see the requirements for applying for this IPO.

Use the lot size calculator to find how many shares you should apply for!

Amanta Healthcare IPO Promoter Holding

Have a look at the table below to check the holdings of Amanta Healthcare Limited’s promoters: Mr. Debajit Choudhury, Ms. Rina Choudhury, Ms. Susmita Mukherjee, Ms. Debahuti Chatterjee, and Ms. Nita Dey.

Share Holding Pre-Issue85.60%
Share Holding Post-Issue63.56%

Note: The value will be calculated using Equity Dilution = Share Holding Pre-Issue –  Share Holding Post-Issue.

Aim of the Amanta Healthcare IPO

The primary aim of the Amanta Healthcare IPO is to raise ₹126.00 crores. On the other hand, Amanta Healthcare has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Amanta Healthcare IPO.

  • To fund capital expenditure requirements for civil construction work and towards the purchase of equipment, plant and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat
  • To fund capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat
  • To General corporate purposes

Should I Invest in the Amanta Healthcare IPO?

Explore the pros and cons of Amanta Healthcare to know whether you should apply or avoid the issue. These pros and cons may help you understand the IPO’s efficiency in generating profits in the coming decades. 

    Pros of Amanta Healthcare IPO

  • The company has a speciality in sterile Liquid manufacturing 
  • It has strong regulatory & Export credentials
  • The company has a strong financial position

Cons of Amanta Healthcare IPO

  • The company’s entire manufacturing operation is concentrated in one facility located in Hariyala, Gujarat.
  • The company has high financial costs and a supplier Risk
  • Company carries a legal liabilities & Financial Leverages. 

How to Apply for the Amanta Healthcare IPO?

Check the steps mentioned below to apply for Amanta Healthcare Limited.

  • Step 1: Conduct thorough research on the Amanta Healthcare IPO GMP, subscription status, issue size, lot size, and other details. 
  • Step 2: Open a demat account on Univest to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
  • Step 3: Make a bid for two lots of 119 shares worth ₹14,994.
  • Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Amanta Healthcare IPO from more than one demat account to increase your chances of allotment. 

How to Check Amanta Healthcare IPO Allotment Status?

You can check whether the Amanta Healthcare IPO allotment has been completed in different ways. These include BSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On BSE

  • Visit the BSE Official Website.
  • Navigate to the IPO Allotment Section. 
  • Select Equity as the issue type. 
  • Choose the Amanta Healthcare IPO.  
  • Choose whether to proceed with the PAN number or the application number. 
  • Submit your details to get the allotment status online. 

Check On the Registrar Portal

  • Visit the registrar portal.
  • Click on the allotment option.
  • Fill in the required details.
  • Click on the submit button to know your Amanta Healthcare IPO allotment status.

Let’s Wrap

Amanta Healthcare IPO is a bookbuilding issue of shares worth ₹126.00 crores. The shares of Amanta Healthcare Limited will be listed on BSE and SME on its tentative listing date of 9th September 2025. Researching the Amanta Healthcare IPO GMP and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Amanta Healthcare IPO

How is the Amanta Healthcare IPO?

Ans. Currently, on 29th August 2025, the Amanta Healthcare IPO GMP (Grey Market Premium) stands at ₹25. It indicates that the estimated listing price could be ₹151 per share. It is a bookbuilding IPO of ₹126.00 crores, comprising a fresh issue of 1.00 crore shares. The face value of each share of Amanta Healthcare Limited is ₹10 per share.

What is the Amanta Healthcare IPO price?

Ans. The Amanta Healthcare IPO price is set at ₹120.00 to ₹126.00 per share.  Retail investors can apply for a minimum of 1 lots consisting of 119 shares worth ₹14,994. Moreover, HNIs are required to bid for a minimum of 14 lots (1,666 shares) worth ₹2,09,916.

Is the Amanta Healthcare IPO good?

Ans. Amanta Healthcare Limited’s revenue increased by 2% from ₹281.61 crores in March 2024 to ₹276.09 crores in March 2025. Moreover, the company’s PAT rose by 189% from ₹3.63 crores to ₹10.50 crores..

Who is the registrar of the Amanta Healthcare IPO?

Ans. MUFG Intime India Private Limited is the registrar of the Amanta Healthcare IPO, responsible for managing the IPO allotment procedure and refund initiation. For any queries regarding the Amanta Healthcare allotment and refund, you can contact Maashitla Securities Private Limited at ipo.helpdesk@linkintime.co.in +91-22-4918 6270. 

What is the issue size of the Amanta Healthcare IPO?  

Ans. Amanta Healthcare IPO is a bookbuilding IPO for 1.00 crore shares worth ₹126.00 crores. Moreover, the IPO is set to open on 1st September 2025 and will be closed on 3rd September 2025. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Amanta Healthcare IPO, download the Amanta Healthcare IPO RHP and Amanta Healthcare IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Upcoming IPOs

IPO NamesExpected Year of IPO
PhonePe IPO2025
Bajaj Energy IPO2025
OYO IPO2025
Amanta Healthcare  IPO2025
Flipkart IPO2025
Zepto IPO2025
boAt IPO2025
Meesho IPO2025
Jio IPO2026
NSE IPO2025

Current & Previous IPOs

CompanyIPO OpenIPO CloseType
ARC Insulation  & Insulators IPO21st August 202525th August 2025SME
Mangal Electricals Industries IPO20th August 202522nd August 2025Mainboard
Patel Retail IPO19th August 202521st August 2025Mainboard
Vikram Solar IPO19th August 202521st August 2025Mainboard
Gem Aromatics IPO19th August 202521st August 2025Mainboard
Shreeji Shipping Global IPO19th August 202521st August 2025Mainboard
LGT Business Connextions IPO19th August 202521st August 2025SME
Studio LSD IPO18th August 202520th August 2025SME
Regaal Resources IPO12th August 202514th August 2025Mainboard
Bluestone Jewellery IPO11th August 202513th August 2025Mainboard
JSW Cement IPO7th August 202511th August 2025Mainboard

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

Also Explore

Best Stocks Multibagger Stocks Penny StocksFundamentally Strong Stocks Sector-Wise StocksPSU /Government Stocks
For the Next 10 YearsFor the Next 5 YearsSolar Penny StocksOn BSESolar Energy SectorPSU Stocks List
Long Term Below 100 RsTop 5 Penny StocksFor Long-TermHospitality Sector PSU Stocks in 2025
Best Bike StocksFor 2025Best Penny Stocks in IndiaPenny SharesHotel SectorGovernment Stocks in 2024
Best Liquor StocksHigh-Growth StocksFor 2025Agriculture SectorGovernment Stocks List
Best Railway StocksUnder 500Penny Stocks Pharma SectorGovernment Stocks in 2025
Best Auto StocksFor 2026Oil and Gas Sector

Univest Screeners

ExclusiveIndicesBreakouts
Buy in Short TermNifty Small Cap 100Daily Fresh Breakouts
Buy in the Long TermNifty MidcapWeekly Breakouts
FII Holdings ChangeNifty BankOversold Stocks
Golden CrossoverSensexNearing Breakout
Upcoming DividendsNifty Fin Service
DII Holdings ChangeBankex
High Dividend StocksNifty Mid Cap 100
Earnings AnnouncedNifty 50
Fundamentally Strong 
Top Gainers
Top Losers
Low Debt Mid Caps
Cash-Rich Small Caps
Volume Shockers
52-Week High 
52-Week Low

Explore Webstories on Univest 

1. Best Time To Buy Dividend Stocks

2. How RBI Policies Affect Dividend Stocks

3. Can Dividend Stocks Beat Inflation

4. What Is The Dividend Aristocrat List

5. Which Indian Psus Offer The Best Dividends

6. Large Cap Vs Small Cap Dividend Stocks

icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
General
arrow down